Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: a randomized, double ‐blind, placebo‐controlled study

Allergy,Volume 0, Issue ja, -Not available-.

Source: Allergy - July 5, 2018 Category: Allergy & Immunology Authors: Martin Metz , Rebecca Torene , Sergio Kaiser , Michael T. Beste , Petra Staubach , Andrea Bauer , Randolf Brehler , Janine Gericke , Martin Letzkus , Nicole Hartmann , Veit J. Erpenbeck , Marcus Maurer Source Type: research